Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Robert H E Friesen"'
Autor:
Boerries Brandenburg, Wouter Koudstaal, Jaap Goudsmit, Vincent Klaren, Chan Tang, Miriam V Bujny, Hans J W M Korse, Ted Kwaks, Jason J Otterstrom, Jarek Juraszek, Antoine M van Oijen, Ronald Vogels, Robert H E Friesen
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e80034 (2013)
Human monoclonal antibodies have been identified which neutralize broad spectra of influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies interfere with infectivity. We distinguish four mechanisms that link the conserved h
Externí odkaz:
https://doaj.org/article/94c3128c61834b27bb660217681e881d
Autor:
Robert H E Friesen, Wouter Koudstaal, Martin H Koldijk, Gerrit Jan Weverling, Just P J Brakenhoff, Peter J Lenting, Koert J Stittelaar, Albert D M E Osterhaus, Ronald Kompier, Jaap Goudsmit
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9106 (2010)
BackgroundThe urgent medical need for innovative approaches to control influenza is emphasized by the widespread resistance of circulating subtype H1N1 viruses to the leading antiviral drug oseltamivir, the pandemic threat posed by the occurrences of
Externí odkaz:
https://doaj.org/article/a18d9b465c634aafa91631ed935c70d4
Autor:
Bart Stoops, Rob J. Vreeken, Chan Tang, Wim Bert Griet Schepens, Rameshwar U. Kadam, Jaap Goudsmit, Bart Rudolf Romanie Kesteleyn, Maria J. P. van Dongen, Wouter Goutier, Jan Vermond, Ronald Vogels, Boerries Brandenburg, Ian A. Wilson, Jarek Juraszek, Christophe Buyck, Robert H. E. Friesen
Publikováno v:
Science. 358:496-502
Broadly reactive drugs for flu Drugs for influenza are limited. For those available, viral resistance is rife. Part of the problem is that the virus is constantly mutating. Kadam et al. tested the cell entry stage of the virus life cycle as a drug ta
Autor:
Mandy Jongeneelen, Maria P. Limberis, M. van der Neut Kolfschoten, A. van Eijgen, Ryan M. B. Hoffman, Nick S. Laursen, David Zuijdgeest, Steffen M. Bernard, Leo L.M. Poon, Ian A. Wilson, Jesper Pallesen, Hannah L. Turner, J. Luo, Sven Blokland, H. van Diepen, R. Straetemans, G. Obmolova, J.A. Kolkman, Jan Vermond, James M. Wilson, Travis Nieusma, Anna Tretiakova, Robert H. E. Friesen, Xueyong Zhu, Chan Tang, Ronald Vogels, Boerries Brandenburg, Andrew B. Ward
Publikováno v:
Science (New York, N.Y.). 362(6414)
Durable influenza protection Vaccines are indispensable for the control and prevention of influenza, but there are several challenges to efficacy. Some individuals respond poorly to vaccination, and virus variation makes targeting optimal antigens di
Autor:
Jaap Goudsmit, C. Ophorst, Ryan M. B. Hoffman, Els C. M. Brinkman-van der Linden, Mandy Jongeneelen, Wouter Koudstaal, Mark J. Kwakkenbos, Esther J. M. Stoop, Ted Kwaks, Jarek Juraszek, Arjen Q. Bakker, Andrew B. Ward, Robert H. E. Friesen, Tim Beaumont, Hergen Spits, Peter Lee, Wenli Yu, Hans J. W. M. Korse, Ian A. Wilson, Gira Bhabha, Damian C. Ekiert, Ronald Vogels, Mark Throsby
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 111(1), 445-450. National Academy of Sciences
The discovery and characterization of broadly neutralizing antibodies (bnAbs) against influenza viruses have raised hopes for the development of monoclonal antibody (mAb)-based immunotherapy and the design of universal influenza vaccines. Only one hu
Autor:
Wouter Koudstaal, Lisette A. H. M. Cornelissen, Just P. J. Brakenhoff, Gerrit Jan Weverling, Martin H. Koldijk, Robert H. E. Friesen, Jaap Goudsmit
Publikováno v:
Journal of infectious diseases, 200(12), 1870-1873. Oxford University Press
The Journal of Infectious Diseases, 200(12), 1870-1873
The Journal of Infectious Diseases
The Journal of Infectious Diseases 200 (2009) 12
The Journal of Infectious Diseases, 200(12), 1870-1873
The Journal of Infectious Diseases
The Journal of Infectious Diseases 200 (2009) 12
New strategies to prevent and treat influenza virus infections are urgently needed. A recently discovered class of monoclonal antibodies (mAbs) neutralizing an unprecedented spectrum of influenza virus subtypes may have the potential for future use i
Autor:
Martin H. Koldijk, Samaneh Mashaghi, Jaap Goudsmit, Antoine M. van Oijen, Chan Tang, Ronald Vogels, Boerries Brandenburg, Jarek Juraszek, Ted Kwaks, Jason J. Otterstrom, Robert H. E. Friesen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 111(48), E5143-E5148. National Academy of Sciences
The ability of antibodies binding the influenza hemagglutinin (HA) protein to neutralize viral infectivity is of key importance in the design of next-generation vaccines and for prophylactic and therapeutic use. The two antibodies CR6261 and CR8020 h
Autor:
Hans J. W. M. Korse, Jaap Goudsmit, Robert H. E. Friesen, Ted Kwaks, Ronald Vogels, Boerries Brandenburg, Wouter Koudstaal, Miriam V. Bujny, Chan Tang, Jarek Juraszek, Jason J. Otterstrom, Vincent Klaren, Antoine M. van Oijen
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e80034 (2013)
PLoS ONE, 8(12):e80034. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, 8(12). Public Library of Science
PLoS ONE, 8(12):e80034. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, 8(12). Public Library of Science
Human monoclonal antibodies have been identified which neutralize broad spectra of influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies interfere with infectivity. We distinguish four mechanisms that link the conserved h
Autor:
Wouter Koudstaal, Hans J. W. M. Korse, C. Dreyfus, David Zuijdgeest, Reza Khayat, Zoltan Metlagel, Mohammed Lamrani, Leo L.M. Poon, Olive T. W. Li, Jaap Goudsmit, Just P. J. Brakenhoff, Robert H. E. Friesen, Jeong Hyun Lee, Andrew B. Ward, Ronald Vogels, Özcan Sahin, Mandy Jongeneelen, Remko Van Der Vlugt, Ian A. Wilson, Damian C. Ekiert, Ted Kwaks, Miriam V. Bujny, Eric Geelen, Martijn Sieuwerts, Malik Peiris, Nick S. Laursen
Publikováno v:
Science, 337(6100), 1343-1348. American Association for the Advancement of Science
Influenza Antibodies, Part B With its ability to reassort in animal hosts like pigs and birds, and to cause pandemics, influenza A viruses are often in the spotlight. However, a substantial portion of the annual flu burden is also the result of influ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ed058a9ac64993a2c3ae641214d4f8
https://europepmc.org/articles/PMC3538841/
https://europepmc.org/articles/PMC3538841/
Autor:
C. Ophorst, Ian A. Wilson, Freek Cox, Damian C. Ekiert, Martin H. Koldijk, Wouter Koudstaal, Malik Peiris, Leo L.M. Poon, Jaap Goudsmit, Wenli Yu, Lisette A. H. M. Cornelissen, Ronald Kompier, Ronald Vogels, Robert H. E. Friesen, Mandy Jongeneelen, Hans J. W. M. Korse, Boerries Brandenburg, Ted Kwaks, Gira Bhabha, Just P. J. Brakenhoff
Publikováno v:
Science, 333(6044), 843-850. American Association for the Advancement of Science
Science 333 (2011) 6044
Science, 333(6044), 843-850
Science 333 (2011) 6044
Science, 333(6044), 843-850
Current flu vaccines provide only limited coverage against seasonal strains of influenza viruses. The identification of VH1-69 antibodies that broadly neutralize almost all influenza A group 1 viruses constituted a breakthrough in the influenza field
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f264ea1f2722b8fa2e76589624794003
https://pure.amc.nl/en/publications/a-highly-conserved-neutralizing-epitope-on-group-2-influenza-a-viruses(32bec0ad-fed5-4ef8-b8bd-0e1cdbd8ebed).html
https://pure.amc.nl/en/publications/a-highly-conserved-neutralizing-epitope-on-group-2-influenza-a-viruses(32bec0ad-fed5-4ef8-b8bd-0e1cdbd8ebed).html